Cagrilintide is supplied as a long-acting amylin analogue for qualified laboratory research. It is intended for a long-acting amylin analogue used in laboratory studies of amylin and calcitonin receptor pharmacology, peptide stability, receptor signalling and combination-pathway research. Available specifications: 5 mg, 10 mg; 10 vials per box. For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.